Limited Competition: Continuation of Chronic Renal Insufficiency Cohort (CRC)
Limited Competition: Continuation of Chronic Renal Insufficiency Cohort (CRC)
批准号:
7901937
负责人:
LAWRENCE JOHN APPEL
金额:
$11.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-04 至 2011-08-31
关键词:
African AmericanAgeAreaAtherosclerosisBaltimoreBiologicalCardiovascular DiseasesChronicChronic Kidney InsufficiencyClinicalCohort AnalysisCohort StudiesCreatinineDataData AnalysesData CollectionDatabasesDiseaseDisease ProgressionEconomic FactorsEligibility DeterminationEnrollmentEthnic OriginEvaluationEventGenderGeneticGlomerular Filtration RateHomocysteineHomocystineHypertensionIncidenceIndigentIndividualInstitutionIntervention TrialKidneyKidney DiseasesLaboratory StudyLeadLocationMarylandMeasurementMedical centerModificationMorbidity - disease rateNested Case-Control StudyObservational StudyOutcomeOutputParticipantPersonsPhysiologicalPopulationPositioning AttributePredictive ValuePrevalenceProtocols documentationPublicationsQuestionnairesRaceRecruitment ActivityRenal functionReportingResearchResearch InfrastructureResearch PersonnelRisk FactorsSex CharacteristicsSpecific qualifier valueSpecimenSystemTelephoneTestingTrainingUniversitiesVisitWorkcardiovascular disorder riskcohortdesigndiabeticdisorder riskfollow-uphealth care deliveryinflammatory markerinstrumentinterestmetropolitannon-diabeticoxidative damagepreventprimary outcomeprogramsprospectiveresearch studysalt intakesuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This proposaldescribes the Johns Hopkins-University ofMaryland field centerforthe Prospective Cohort
Study of Chronic Renal Insufficiency, also termed CRIC. The incidence and prevalence of endstage
kidney disease are relentlessly increasing, along with attendant co-morbidities, particularly cardiovascular
disease. CRIC is a longitudinal, observational study that will determine the risk factors for progressionof
chronic renal insufficiency and the risk factors for cardiovascular disease in a cohort of individuals with
impaired kidney function. Participants will be 3,000 individuals (250 at Hopkins, 250 at Maryland),50%
diabetic and 50% non-diabetic, with an estimated glomerular filtration rate (GFR) of 30-70 ml/min/1.73 m2.
The primary recruitment strategy will be to identify individuals with an elevated creatinine thatcorresponds
to this GFR range. Both Hopkins and U.Maryland have the proven capacity to generate lists of such
individuals. These 2 medical centers are the largest health care delivery systems in the Baltimore
metropolitan area, which is populated by 1.6 million persons. The locations of the two institutions should
acilitate enrollment of a diverse cohort, many of whom will be indigent. Baseline data will be collectedover
3 visits (a brief eligibility visit and 2 subsequent visits). Outcomeswill be ascertained at an annual in-person
Follow-up visit and by telephone surveillance. Core measurements will include questionnaires, GFRs
chocardiograms, and biological specimens. Study investigators have a proven track record of successfully
designing and conducting large-scale, collaborative research studies. Specifically, they havesuccessfully
¿ecruited large cohorts of participants, have achieved high follow-up rates, have collected virtually all of the
Imajor measurements proposed in this study, and have made substantive scientific contributions through
publication and presentation of their findings. The impressive infrastructure of the two institutions and the
(large population of the Baltimore metropolitan area will further enhance the potential for success. Inshort,
he Hopkins-U.Maryland field center is extremely well-positioned to accomplish each of the major task:
equired of the CRIC field centers and to contribute to the overall success of this vitally important study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vitamin D Supplements to Prevent Falls in Older Adults: A Dose-Response Trial
-
批准号:9462039
-
项目类别:
-
资助金额:$173.12万
-
财政年份:2014
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
Vitamin D Supplements to Prevent Falls in Older Adults: A Dose-Response Trial
-
批准号:8877383
-
项目类别:
-
资助金额:$167.96万
-
财政年份:2014
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
Vitamin D Supplements to Prevent Falls in Older Adults: A Dose-Response Trial
-
批准号:8739913
-
项目类别:
-
资助金额:$99.94万
-
财政年份:2014
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
Vitamin D Supplements to Prevent Falls in Older Adults: A Dose-Response Trial
-
批准号:9041778
-
项目类别:
-
资助金额:$9.8万
-
财政年份:2014
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
Integrated Clinical-Behavioral Interventions to Accomplish Weight Loss
-
批准号:7192066
-
项目类别:
-
资助金额:$94.06万
-
财政年份:2006
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
Integrated Clinical-Behavioral Interventions to Accomplish Weight Loss
-
批准号:7480353
-
项目类别:
-
资助金额:$126.16万
-
财政年份:2006
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
Integrated Clinical-Behavioral Interventions to Accomplish Weight Loss
-
批准号:7288286
-
项目类别:
-
资助金额:$128.6万
-
财政年份:2006
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
Integrated Clinical-Behavioral Interventions to Accomplish Weight Loss
-
批准号:7884302
-
项目类别:
-
资助金额:$92.34万
-
财政年份:2006
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
CRIC STUDY
-
批准号:7604571
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2006
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
Integrated Clinical-Behavioral Interventions to Accomplish Weight Loss
-
批准号:7658838
-
项目类别:
-
资助金额:$129.12万
-
财政年份:2006
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
CRIC STUDY
-
批准号:7378842
-
项目类别:
-
资助金额:$3.52万
-
财政年份:2005
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
CRIC STUDY
-
批准号:7200763
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2005
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
WEIGHT LOSS MAINTENANCE TRIAL
-
批准号:7249130
-
项目类别:
-
资助金额:$14.92万
-
财政年份:2003
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
WEIGHT LOSS MAINTENANCE TRIAL
-
批准号:7174238
-
项目类别:
-
资助金额:$20.21万
-
财政年份:2003
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
WEIGHT LOSS MAINTENANCE TRIAL
-
批准号:6999311
-
项目类别:
-
资助金额:$42.17万
-
财政年份:2003
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
CRIC Study
-
批准号:7044714
-
项目类别:
-
资助金额:$0.52万
-
财政年份:2003
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
PREMIER Maintenance Trial
-
批准号:6698117
-
项目类别:
-
资助金额:$71.13万
-
财政年份:2003
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
WEIGHT LOSS MAINTENANCE TRIAL
-
批准号:6840857
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2003
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
PREMIER Maintenance Trial
-
批准号:6573004
-
项目类别:
-
资助金额:$45.89万
-
财政年份:2003
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
Macronutrients and Cardiovascular Risk
-
批准号:7033061
-
项目类别:
-
资助金额:$112.54万
-
财政年份:2002
-
负责人:LAWRENCE JOHN APPEL
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: